ARISE I Consensus Statement on the Management of Chronic Subdural Hematoma

Stroke. 2024 May;55(5):1438-1448. doi: 10.1161/STROKEAHA.123.044129. Epub 2024 Apr 22.

Abstract

ARISE (Aneurysm/AVM/cSDH Roundtable Discussion With Industry and Stroke Experts) organized a one-and-a-half day meeting and workshop and brought together representatives from academia, industry, and government to discuss the most promising approaches to improve outcomes for patients with chronic subdural hematoma (cSDH). The emerging role of middle meningeal artery embolization in clinical practice and the design of current and potential future trials were the primary focuses of discussion. Existing evidence for imaging, indications, agents, and techniques was reviewed, and areas of priority for study and key questions surrounding the development of new and existing treatments for cSDH were identified. Multiple randomized, controlled trials have met their primary efficacy end points, providing high-level evidence that middle meningeal artery embolization is a potent adjunctive therapy to the standard (surgical and nonsurgical) management of neurologically stable cSDH patients in terms of reducing rates of disease recurrence. Pooled data analyses following the formal conclusion and publication of these trials will form a robust foundation upon which guidelines can be strengthened for cSDH treatment modalities and optimal patient selection, as well as delineate future lines of investigation.

Keywords: arteries; capillaries; hematoma; inflammation; neurology; neurosurgery; subdural.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Consensus
  • Embolization, Therapeutic / methods
  • Hematoma, Subdural, Chronic* / therapy
  • Humans
  • Randomized Controlled Trials as Topic